In an interview, Andrew Evens, DO, an expert in hematology and oncology, will discuss a…

In this ASH 2023 interview, Dr. Jos Melenhorst discusses a collaborative study on single-cell multi-omics…

By. Terry Mamounas Date: 12/07/2023In a collaborative study between NVP and RT, led by oncologist…

Zandra Klippel, MD, Global Product Head, Sanofi – Phase 3 IsKia trial of Sarclisa® (isatuximab)…

By: Hatem Azim, MD Date. 12/08/2023At SABCS 2023, a discussion on fertility preservation and assisted reproductive…

By. Valeria Santini, MDDate: 12/13/2023At the ASH 2023 symposium, Valeria Santini, MD, a distinguished medical…

At ASH 2023, Ola Landgren, MD, Professor of Medicine and Chief Division of Myeloma at…

In a discussion on cancer science, Wassim Mchayleh, MD, explores the role of Minimal Residual…

Wassim Mchayleh, MD, a speaker at the Medical Data and Analysis Symposium (MDAS), discusses the…

Amidst the atmosphere of SABCS 2023, and at the center was Yara Abdou, MD, a…